Toxicokinetics and lack of uterotropic effect of orally administered S-equol

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

JAMA · 2002 · 15.8K citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

The Carbon Monoxide-binding Pigment of Liver Microsomes

Tsuneo Omura, Ryo Sato · Journal of Biological Chemistry · 1964 · 11.8K citations · Full text

Life Sciences, Biochemistry, Chemistry +8

THE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVE

Thorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf et al. · Drug Metabolism and Disposition · 2003 · 784 citations

Medicine, Pharmacokinetics, Pharmacology +17

S-Equol, a potent ligand for estrogen receptor β, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora1–4,

Kenneth D.R. Setchell, Carlo Clerici, Edwin D. Lephart et al. · American Journal of Clinical Nutrition · 2005 · 462 citations

Life Sciences, Endocrinology, Pharmacology +15

A simplified method of quantitating protein using the biuret and phenol reagents

S. Tsuyoshi Ohnishi, James K. Barr · Analytical Biochemistry · 1978 · 454 citations

Life Sciences, Biochemistry, Molecular Biology +6